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Survival extrapolation using the
poly-Weibull model
Nikolaos Demiris,1 David Lunn2 and
Linda D Sharples2
Abstract
Recent studies of (cost-) effectiveness in cardiothoracic transplantation have required estimation of
mean survival over the lifetime of the recipients. In order to calculate mean survival, the complete
survivor curve is required but is often not fully observed, so that survival extrapolation is necessary.
After transplantation, the hazard function is bathtub-shaped, reflecting latent competing risks which
operate additively in overlapping time periods. The poly-Weibull distribution is a flexible parametric
model that may be used to extrapolate survival and has a natural competing risks interpretation. In
addition, treatment effects and subgroups can be modelled separately for each component of risk. We
describe the model and develop inference procedures using freely available software. The methods are
applied to two problems from cardiothoracic transplantation.
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1 Introduction
In recent studies of (cost-)eﬀectiveness in transplantation, the quantity of interest has been mean
survival over the lifetime of the recipients. Two examples are: (1) estimation of the diﬀerence in mean
survival for recipients of a single lung transplant (SLT) compared with a double lung transplant
(DLT), and (2) potential mean life years gained (LYG) using a novel device for preservation of
donor hearts during transportation to the recipients; the device is expected to incur high costs during
the transplant procedure but the full beneﬁt will only be accrued over several years after heart
transplantation. Mean survival is estimated as the area under the survivor curve but, in common
with many cases, the complete survivor curve is not observed at the time of the study. Thus, we can
either estimate the truncated mean survival deﬁned by the period over which the survivor curve is
observed, or we can use some form of survival extrapolation. The former will give an accurate
estimate of a quantity that is of limited interest, while the second gives a possibly less accurate
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estimate of mean survival but answers the question of interest. Therefore calculation of the full
beneﬁt of new therapies and comparisons of the life expectancy of diﬀerent subgroups depends on
survival extrapolation.
Extrapolation of survivor curves in cost-eﬀectiveness studies is routine but is often completed in
ad hoc ways, including extrapolation of constant hazard rates, which at the very least ignores the
increasing risk due to ageing. In transplantation, hazards have been observed to be bathtub- or
U-shaped. Empirical hazards are high in the period immediately after transplantation due to the
procedure itself and associated immunological events. This is followed by a steep decrease to a
period of relative stability reﬂected by constant hazards, and thereafter hazards increase due to
the ageing of the participants and the chronic complications of transplantation.1 In this context, and
others, the bathtub-shaped hazard functions reﬂect latent competing risks that operate simultaneously
in an additive manner. They are common to many surgical applications, for example in the study
carried out by Blackstone et al.,2 the hazard following heart valve replacement operations was
decomposed into additive overlapping components reﬂecting similar latent competing risks.
One further complication in transplantation is that the cause of death is either unknown or its
determination is often not straightforward. For example, an episode of acute rejection of the
transplanted organ will result in increased immunosuppression therapy, which in turn leaves the
recipient at risk of infections and further immunological compromise. If the patient then dies, it is
not clear whether the cause of death is acute rejection, infection or primary donor organ failure, and
all three may contribute. Therefore cause of death is often considered unknown so that we cannot
model the competing risks directly, we are required to infer the contributions of the competing risks
from the shape of the hazard function.
The above features suggest that a parametric model like a mixture may be appropriate for this
task. Suﬃcient conditions for the shape of the hazard rate are given by Glaser.3 In particular, he
shows that a mixture of two Weibull distributions cannot result in bathtub-shaped hazard rate,
correcting a contention due to Kao.4 In contrast, poly-Weibull models5,6 in which the overall hazard
is the sum of several independent components appear natural in this context. Poly-Weibull models
have been used in the competing risks framework, typically with diﬀerent objectives to the ones that
concern us here. Speciﬁcally, we are not interested in marginal (or ‘net’) hazards, cumulative
incidence functions or examination of the eﬀect of removing a risk component. Merely, we shall
use such models as ﬂexible parametric assumptions that may be reasonable for extrapolating
survival while their parameters retain a natural interpretation. Gelber et al.7 used a hybrid
approach in which a parametric model is ﬁtted to the tail of the survival curve while the ‘early’
part is treated non-parametrically. The proposed model also has close connections to other ‘rich’
parametric models such as fractional polynomial regression8 (FPR) and generalised additive models9
(GAM). However, each component in our model retains a competing risks interpretation in terms of
the survival outcome. This is not typically the case with the hybrid, FPR and GAM models.
In our ﬁrst example, comparison of single and double lung transplantation as treatment options
over the lifetime of the recipients is of primary interest, and can be combined with data on quality of
life in a more general analysis. In the second example, the assessment of a novel organ preservation
system, the main focus is estimation of mean survival within a cost-eﬀectiveness analysis. In both
these contexts, it is attractive to adopt a Bayesian approach since diverse sources of evidence often
need to be synethesised in a coherent framework.10 In our applications, the clinical context dictates
the nature of the components of the hazard function and this information can be incorporated via
prior distributions in a Bayesian approach. In addition, simulation-based techniques seem especially
advantageous as the correlation structures that may be present are propagated through to the
evaluation of (non-linear) functionals of the basic model parameters, in this case, the mean
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survival. The development of the WinBUGS software11,12 has made the routine ﬁtting of fairly
complicated models possible and as a result of these transplantation studies, the poly-Weibull
model has been programmed into WinBUGS and is freely available. The remainder of this article
is organised as follows. The modelling framework is described in Section 2 and in Section 3 we
describe the details of the inference procedure. Implementation of the methods to answer
substantive questions in cardiothoracic transplantation is presented in Section 4, while this article
is concluded with some discussion in Section 5. The details of the Markov chain Monte Carlo
(MCMC) algorithm can be found in Appendix.
2 Poly-Weibull model
Suppose that an individual is subject to m independent sources of risk that operate additively.
Assume further that the distribution of each of the components may be suﬃciently described by a
Weibull form with density f(t | , l)¼ lt1 exp(lt). Then, the observed event time is said to
follow a poly-Weibull distribution. The hazard function arises as the sum of the m independent
Weibull-type hazards:
hðtÞ ¼
Xm
j¼1
jljtj1, ð2:1Þ
the survivor function is
SðtÞ ¼ exp 
Z t
0
hðsÞds
 
¼ exp 
Xm
j¼1
ljtj
 !
ð2:2Þ
and the density is
f ðtÞ ¼ hðtÞSðtÞ ¼ exp 
Xm
j¼1
ljtj
 !Xm
j¼1
jljtj1: ð2:3Þ
In theory, identiﬁability problems (and improper posterior distributions) can be encountered when
the shape parameters 1, 2,. . ., m are equal. In practice, in the absence of causes of death,
identiﬁability will also be problematic whenever each of the m hazard components are not
suﬃciently distinct given the data at hand. We will further examine this issue in Section 4.
Covariate eﬀects can be modelled via the rate parameters l1, l2,. . ., lm in the usual way
logðljÞ ¼ 0j þ 1jz1 þ    þ pjzp: ð2:4Þ
For complete ﬂexibility, covariate eﬀects may also be incorporated onto the shape parameters,
logðjÞ ¼ 0j þ 1jz1 þ    þ pjzp: ð2:5Þ
2.1 Mean survival and discounted mean survival
In many health economic applications, mean survival is of primary interest,
EðTÞ ¼
Z 1
0
SðsÞds: ð2:6Þ
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Since future survival is considered less valuable than current survival, it is usual to discount future
survival at an annual discount rate d. The discounted mean survival is given by
EðTd Þ ¼
X1
t¼0
R tþ1
t SðsÞds
ð1þ d Þt : ð2:7Þ
For convenience, this can be approximated using the trapezium rule over some time horizon h,
EðT^dÞ ¼ 0:5
Xh
t¼0
Sðtþ 1Þ þ SðtÞ
ð1þ d Þt , ð2:8Þ
and in most cases, this can be calculated numerically using simulation or other methods.
3 Bayesian Inference
3.1 Likelihood
We shall be concerned with inference based on observed survival data {y¼ (ti, i), i¼ 1,. . ., n}, where
for individual i, ti denotes the time to the event or to censoring and i indicates whether i was
censored (i¼ 0) or not (i¼ 1). When the observations of distinct individuals are conditionally
independent, the likelihood function can be written as
Lðm, k j yÞ ¼
Yn
i¼1
SðtiÞhðtiÞi , ð3:1Þ
where S(t) and h(t) are deﬁned in (2.2) and (2.1) while m and k denote the vectors of the shape (m1,
m2,. . ., mm) and rate (k1, k2,. . ., km) parameters, respectively.
3.2 Prior specification and identifiability
The choice of priors should be dictated by subject-matter knowledge. It has been empirically
observed that a bathtub shape is the most common shape of the hazard rate following
transplantation. This suggests that m¼ 2 (often referred to as the bi-Weibull model)13 and m¼ 3
are the most likely candidates. In all the examples, considered values for m between 1 and 4 were
investigated, with the case m¼ 1 used to conﬁrm the validity of our results when compared to the
standard Weibull model.
In the case of no covariate eﬀects, we specify vague, log-normal priors for the rate parameters: log
lj  Normal(0, 1002), j¼ 1,. . ., m. If covariate eﬀects are included, however, we specify Normal(0,
1002) priors for the coeﬃcients of those eﬀects. For the shape parameters, we note that the
immediately post-operative hazard must be decreasing, and so 12 (0, 1) (assuming the ﬁrst poly-
Weibull component is designated as corresponding to immediately post-operative risk). An obvious
prior choice is then 1  Uniform(0, 1). Subsequent components of risk may be either increasing or
decreasing, and so for these, we specify log-normal priors with mode 1: log j  Normalð0, 2 Þ,
j¼ 2,. . ., m. We choose  so that shape parameters greater than 15 have only 1% prior
probability: ¼ log(15)/2.33¼ 1.16. Note that this induces greater prior weight to the region
where j> 1 but does not preclude j< 1 values. We will not usually wish to apply covariate
eﬀects to the shape parameters, but in cases where this is desirable, we again specify vague
Normal(0, 1002) for the coeﬃcients, 0j, 1j, etc.
To ensure identiﬁability of the individual hazard components we impose an ordering constraint
on the shape parameters, such that 1<2<   <m. This is necessary because, with the same
parameters, the individual components have identical likelihood contributions. Hence, if
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unordered, the parameters might switch roles during the MCMC simulation giving, for each
parameter, posterior distributions that are a mixture over the supported values. The constraint is
applied by multiplying the joint prior by an indicator function  ¼Qm1j¼1 Iðjþ1  j Þ, where I(x)¼ 1
if x> 0, and I(x)¼ 0 otherwise.
In cases where covariate eﬀects are to be included for the shape parameters, then the ordering
constraint is somewhat more diﬃcult to apply, except in the absence of covariate eﬀects for the rates,
where we would be able to impose l1< l2<   < lm instead, say. When covariate eﬀects are included
for both sets of parameters, we impose the constraint that 1<2<   <m for all possible
combinations of observed covariate values. The indicator g then becomes
Q2
k¼1
Qm1
j¼1 Ckj, where
C1j¼ I(minl{w(j+1)l}minl{wjl}) and C2j¼ I(maxl{w(j+1)l}maxl{wjl}). Here, wjl denotes the
lth element of the 2p-dimensional vector wj¼W j, where p is the number of covariates, j¼ (0j,
1j,. . ., pj)
0 andW a 2p (p+1) matrix containing ones in column 1, and every possible combination
of minimum and maximum observed values for each covariate in columns 2–(p+1), e.g. when p¼ 2:
W ¼
1 min z1 min z2
1 min z1 max z2
1 max z1 min z2
1 max z1 max z2
0
BB@
1
CCA:
Techniques for imposing such constraints in BUGS using ‘auxiliary data’ are illustrated in
Appendix. In contrast to our approach, the methods presented by Davison and Louzada-Neto6
using Laplace’s method are not straightforward to extend when covariates are available and an
alternative approach based on Gibbs sampling was developed by Mazucheli et al.14 who appear to
have overlooked the label switching issue.
3.3 Implementation
The details of the MCMC algorithm we used can be found in Appendix, including details of the
implementation of the poly-Weibull distribution in the WinBUGS Development Interface.15
Evaluating the summaries of interest to health economists, such as the mean survival and the
LYG for diﬀerent covariate levels is straightforward in our simulation-based approach.
Speciﬁcally, sampling from non-linear functionals of the basic model parameters requires no
additional coding. For each model ﬁtted, we calculated the deviance information criterion (DIC)
described in Spiegelhalter et al.16 However, due to skewness in some of the posterior distributions,
which can lead to poor estimates of the ‘eﬀective number of parameters’, we prefer to use the
posterior mean deviance, penalised by the actual number of parameters (since the model is non-
hierarchical), as our model selection criterion, alongside consideration of coeﬃcients’ credible
intervals. Plummer17 discusses the performance of DIC within the framework of penalised loss
functions and cross-validation. On related work, Draper and Krnjajic18 discuss the equivalence of
minimising the DIC and maximising the log-scoring rule using cross-validation. This connection was
ﬁrst established by Stone19 for the Akaike information criterion.
4 Application to transplantation data
In Section 1, we brieﬂy described the two studies in cardiothoracic transplantation that motivated
this study. The poly-Weibull models were developed to estimate mean survival after transplantation
where survival extrapolation was required. The ﬁrst problem relates to diﬀerent lung transplant
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procedures and the second is concerned with the eﬀect on life expectancy of cold ischaemic time (IT)
in heart transplantation.
4.1 Assessing different transplant types
Single lung transplantation (SLT), as opposed to double lung transplantation (DLT), may be used
for some patient groups with severe lung disease and it allows two patients to be treated by a single
organ donor. In addition, a donor may have only one suitable lung. However, SLT may be
considered as a partial treatment and there is some evidence that post-transplant survival may be
worse for SLT recipients.20 However, whether the eﬀect is mainly associated with poorer operative
survival, background survival or chronic complications remains unclear. In addition, the impact on
life expectancy for the transplant types is important when deciding whether to accept a SLT when
oﬀered. Data from Papworth, one of the UK’s specialist cardiothoracic hospitals with a programme
of heart and lung transplantation, were used. The dataset consists of 338 patients presenting for
lung transplantation mainly due to either chronic obstructive pulmonary disease or pulmonary
ﬁbrosis, conditions for which single lung transplantation is a possibility. There were 173 single
and 165 double lung transplants out of whom 144 and 79, respectively, died before the end of the
study, while the remaining 115 patients were alive at the time of data analysis. Cumulative hazards
are plotted in Figure 1, while product-limit survival estimates in Figure 2. It is evident from both
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Figure 1. Cumulative hazard estimates for lung transplant recipients.
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ﬁgures that there is a high death rate which decreases before slowly increasing in the long term. The
single lung patients clearly have worse survival. The cumulative hazard plot indicates that this is
most evident in the longer term.
A simple Weibull model (m ¼ 1) was not suﬃcient to describe the data. Within the class of bi-
Weibull models, several choices exist for the combination of distinct shape and rate parameters for
each risk component and transplant type. In particular, a small number of models are hard to
choose between by inspecting the posterior summaries for the diﬀerent parameters. However, all
the ‘highly likely’ models possess a common discernible feature: they suggest only small diﬀerences
in the early phase but SLT recipients show much greater attrition in the longer term component.
This ﬁnding is intuitively reasonable and appears clinically sensible. Posterior mean deviance
estimates for a range of models are given in Table 1.
There is a clear improvement in ﬁt for models with two components compared with the Weibull
model, and a clear eﬀect of the covariate SLT. However, beyond that, within the bounds of sampling
error, the deviance is the same for all the two-component models investigated. Thus, in the interest
of parsimony, the two-component model with SLT having an eﬀect on the later hazards only would
seem to be the optimal choice. Parameter estimates for this model are given in Table 2. The SLT
group had appreciably higher long-term risks but the 95% credible intervals are wide due to the lack
of suﬃcient data to obtain more precise inference results. This suggests we cannot rule out an eﬀect
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Figure 2. Product-limit survival estimates for lung transplant recipients.
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of SLT on other model parameters, and interpretation of estimates of mean survival should be
cautious while product-limit survival estimates are plotted in Figure 2.
The model with m ¼ 3 was not essentially identiﬁable as the parameter estimates for the second
hazard component are very similar to the estimates of the third component. Thus, considering
models with m> 2 appears unnecessary in this example.
4.2 Cold Ischaemic Time effect
Our second study is concerned with the health economic evaluation of a novel device for storing
donated hearts for transplantation. The length of time between excision of a heart from the donor
and successful implant into the recipient is called IT. Longer IT has a detrimental eﬀect on survival,
particularly in the short term.21 In the UK, average IT has been steadily increasing in recent years.22
Traditionally, donated organs are packed in ice during transfer from the donor hospital to the
transplant centre but the new devices store the hearts in warm, oxygenated donor blood,
supplemented with nutrients. It is claimed by the manufacturers that the new machine could
eﬀectively reduce the IT to 60 min. However, the machine is likely to be expensive and the
potential health gains, evaluated over the lifetime of the patients, will dictate whether the
intervention can be termed cost-eﬀective or not. Device regulation is less well developed when
compared to drug regulation and an analysis of this kind could help to decide whether a
randomised controlled trial of the new device is likely to be a good use of resources.
A preliminary analysis of heart transplant activity from the UK was conducted by Goldsmith
et al.23 This analysis included 4335 patients of whom 2279 died before the end of the study, with
Table 2. Posterior mean and 95% credible intervals for the different shapes () and log-rate ()
parameters
Parameter estimate (95% credible interval)
01 1.12 (1.32,0.93)
1 0.54 (0.45, 0.64)
02 8.67 (35.7,5.46)
12 2.42 (0.68, 29.9)
2 2.54 (1.71, 3.56)
Mean survival SL 4.96 (4.32, 5.75)
Mean survival DL 8.78 (6.14, 13.7)
Survival difference (DL–SL) 3.83 (1.04, 8.72)
Note: SL, single lung and DL, double lung.
Subscript 1 (2) refers to the early (late) risk component.
Table 1. Posterior mean deviance for different models
Model Mean deviance
Weibull (m¼1) with covariate on rate 979.1
Poly-Weibull (m¼2) no covariates 966
Poly-Weibull (m¼2) covariate on rate parameters only 958.7
Poly-Weibull (m¼2) covariate on ‘late’ rate parameter only 958.2
Poly-Weibull (m¼2) covariate on rate and shape parameters 977.3
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median survival of 10.4 years. The mean IT was 191 min and standard deviation was 59 min. The
authors used a Cox24 proportional hazard regression model with the hazard ratio for IT piecewise
constant, with a single ﬁxed change-point after the initial operative hazards had passed. It showed
that short ITs can confer a signiﬁcant advantage in the early (post-transplant) survival. However,
the eﬀect appears smaller in the latter segment of the survival curve and in particular, the IT eﬀect
beyond the initial period is not ‘statistically signiﬁcant’. The length of the initial period was hard to
estimate using a change-point model but it appeared that the estimate of the overall LYG (deﬁned as
the diﬀerence in mean survival) was not sensitive to varying the period between 6 and 12 months.
One advantage of the poly-Weibull distribution we shall consider is that a choice of the length of the
initial period is unnecessary since the various risk components overlap and there is no assumption of
an instantaneous jump in relative hazards. A related issue regarding health economic evaluation, is
the sensitivity of the estimated LYG to the piecewise-constant relative hazards assumption.
Speciﬁcally, assuming diﬀerent IT eﬀects in the early and late phases can cause large changes in
the estimated LYG with severe overestimation bias when a common eﬀect is assumed by the model
and extrapolated over the lifetime. Choices of this kind are naturally dealt within the parametric
approach we adopt in this article. Finally, and perhaps more importantly, any non- or semi-
parametric method necessitates some reliable technique for extrapolating the observed survival.
Goldsmith et al.23 used the estimated hazard rate in years 13–20 to model crudely the shape of
the hazard rate beyond 20 years, for which no data were available. In the model we propose here,
this problem is inherently accommodated by the parametric survival distribution.
Several models were considered starting with the simplest model with m¼ 1, i.e. the standard
Weibull model. The Weibull model was not ﬂexible enough to describe the bathtub-shaped hazards
and gave a poor ﬁt. In transplantation, a model with two hazard components can be thought of as
corresponding to the early post-operative risk and the long-term risks of chronic complications from
transplantation and the ageing process. The long-term risks could potentially consist of more than one
part but since we have no reliable information on the cause of death for these individuals they cannot
be delineated and it appears that the bi-Weibull model may represent the best practical choice in this
case. We loosely refer to the two risk components as the ‘early’ and ‘late’ hazards. Models with m ¼ 3
orm¼ 4 appeared unnecessary both by inspecting the posterior estimates of the model parameters and
using the estimated mean deviance. A proportional hazards model for risk component j was ﬁtted on
the rate parameter by assuming that log(lj)¼ 0j+1j IT. (Models with IT eﬀects also on the shape
parameters were considered but gave estimated coeﬃcients, for the eﬀects of IT on shape, that were
essentially zero.) The results from the ﬁtted bi-Weibull model can be found in Table 3 (referred to as
‘unconstrained model’). Parameter learning was generally very quick for the early part of the hazard
while convergence was slower for the later hazard component. In sensitivity analyses, various
parameterisations were attempted, including (l1 ¼ 21, l2 ¼ 112, 1 ¼
 1
 2
and 2¼ 1 2) as proposed
by Louzada-Neto,13 with negligible eﬀect. This seems natural since the data are more sparse in the
latter part, giving rise to a ﬂatter likelihood. Convergence was obtained with a burn in of at most
10 000 iterations. However, due to high autocorrelation in the simulated chains for some parameters,
500 000 iterations of the Gibbs sampler, in total, were performed in order to obtain accurate
inferences. On a 3.06 GHz machine, this took around 22 h for the model presented in Table 3.
The estimates we derive are slightly diﬀerent to the results obtained by Goldsmith et al.23
although the ﬁndings are not materially diﬀerent. In particular, the IT eﬀect is strong in the early
part of the survival curve but negative, although not ‘statistically signiﬁcant’, in the latter part. A
negative eﬀect of IT is considered implausible by the transplant clinicians, although this was not
known when the prior distributions were determined, and has a large eﬀect on the estimates of
potential LYG. Mean survival and the LYG for diﬀerent levels of IT are presented in Table 4.
Demiris et al. 295
For the model presented in Table 3, i.e. with covariate eﬀects on both rates and no constraints on the
second component, a posterior median of 0.901 life years are gained when the IT is reduced from
its average of 191 to 60 min. Two alternative assumptions regarding the second component were
considered: (1) where the coeﬃcient is constrained to be non-negative (results presented in Table 3);
and (2) where the coeﬃcient is ﬁxed at zero. These gave point estimates for LYG of 1.66 and 1.09,
respectively. Of course, this assumes that the IT of 60 min can be achieved in practice and that
changing IT will result in the predicted change in survival rates, irrespective of other donor and
recipient factors. However, it does provide estimates for the potential gain in survival. These results
are to be contrasted to the costs of such systems. For example, if health care providers are willing to
pay 30 000 per life year gained, the preservation system (including base system, consumables and
staﬃng) must cost no more than 50 000 (1.66  30 000) per patient if the constrained analysis is
appropriate, or 33 000 (1.09  30 000) if the eﬀect is restricted to the early post-operative
component. Thus, such machines may not be cost-eﬀective for relatively small IT, but they may
prove very cost-eﬀective (as well as clinically eﬀective) in certain circumstances. Long ITs may be
less common in Europe (see Figure 3 for the distribution of the observed ITs in the UK) but do arise
frequently in countries like Australia and Canada. Further, using such systems may still prove cost-
eﬀective in smaller countries when long ITs are anticipated. In summary, our ﬁndings suggest that
Table 4. Posterior summaries for the mean survival, the mean survival if the IT is reduced to 60 min and the
corresponding LYG
Lifetime functions
Mean survival Mean survival at 60 min LYG
Unconstrained model
Mean 12.1 11.2 0.901
95% CI (11.6, 12.6) (9.06, 14.0) (3.26, 2.04)
IT effect constrained to be positive
Mean 11.9 13.6 1.66
95% CI (11.5, 12.4) (12.6, 15.6) (0.892, 3.69)
IT effect ¼ 0
Mean 11.9 13.0 1.09
95% CI (11.5, 12.4) (12.4, 13.7) (0.646, 1.48)
Note: CI, confidence interval.
Table 3. Posterior mean and 95% credible intervals for the different IT effect parameters
Parameters per hazard component
i 0i 1i (per hour)
Unconstrained model
Early part 0.289 (0.273, 0.305) 1.45 (1.51, 1.39) 0.226 (0.127, 0.323)
Late part 2.58 (2.36, 2.83) 7.62 (8.34, 6.98) 0.195 (0.475, 0.0830)
IT effect constrained to be positive
Early part 0.288 (0.272, 0.304) 1.44 (1.50, 1.38) 0.197 (0.10, 0.29)
Late part 2.572 (2.353, 2.817) 7.55 (8.24, 6.93) 0.067 (0.002, 0.23)
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reducing IT could improve average post-transplant survival over the lifetime of the patients by
between 1.1 and 1.7 years depending on model assumptions, but the cost-eﬀectiveness of the
donor organ maintenance systems will depend on the exact costs and the clinical context in which
it is used.
5 Discussion
We have presented methods for survival extrapolation using ﬂexible parametric models that have
been previously used within the competing risks framework. The poly-Weibull function has been
incorporated into the freely available software, namely WinBUGS, making its implementation
straightforward since the details are not more complicated than any other distribution within the
package, excepting the requirement for identiﬁability constraints.
This study was motivated by two problems from the ﬁeld of cardiothoracic transplantation and
these applications demonstrate the simplicity of the approach. The IT example is typical of cost-
eﬀectiveness analyses in which there is a high initial cost, but for which the full beneﬁt is only
accrued over the lifetime of the patients. Thus, it is important to extrapolate survival in order to
estimate the potential beneﬁt and therefore the value of further assessment of the technology. In
addition to the poly-Weibull providing a ﬂexible parametric distribution for this purpose, there is no
need to make the arbitrary choices surrounding time-varying hazards that were required in a suitable
semi-parametric approach. Using this method, we were able to provide some guidance on acceptable
costs for the heart preservation system.
There has been recent interest20 in the utility of SLT transplants and whether the ability to treat
two individuals from the transplant list outperforms the potential LYG from DLT, at least in the
cases where both these choices are an option. The comparison between SLT and DLT provides an
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Figure 3. The distribution of the observed ITs.
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indication of the diﬀerence in life expectancy, which is considerable and, combined with the poorer
quality of life associated with SLT, suggests that it should be used selectively. However, credible
intervals are wide and this analysis should be revisited in the future. The ﬂexible parametric models
of this article could be a signiﬁcant part of such a study.
In our examples, identiﬁability issues have been tackled via the use of ordering constraints.
Occasionally, we may wish to include covariate eﬀects for both the rate and shape parameters
simultaneously. In such cases, the proposed constraint is increasingly diﬃcult to satisfy, during
the MCMC simulation, as the number of covariates increases. It may be preferable, therefore, to
apply some form of post-analysis relabelling algorithm instead, as discussed by Jasra et al.,25 to
impose the required constraint. Jasra et al.25 also discuss more advanced techniques that may be of
use in situations where the hazard components are not well separated. Another option may be to
incorporate prior information on the model parameters if it is available. Otherwise the model may
need to be simpliﬁed by combining diﬀerent sources of hazard. It was not necessary to use strong
priors in our studies, and results were robust to a range of prior distributions.
There are alternative approaches for ﬂexible hazard modelling. Various three-parameter
distributions have been proposed in the literature.26,27 Models of this kind may be appropriate in
some cases and they can result in U-shaped hazards. However, some identiﬁability issues can arise
when estimating all three parameters and the choice of the optimal parametrisation is often not
straightforward. Also, the interpretation of the model parameters is not always natural in terms of
clinical quantities. Finally, incorporating covariates can be complicated in these approaches while
both categorical and continuous covariates are simply incorporated within the proposed methods of
this article, and retain a natural interpretation.
One potential beneﬁt of using parametric survival curves is that we are able to extrapolate beyond
the data and calculate mean survival, a commonly used measure of eﬀect for health economic
analyses. This approach allows us to divide hazards into early and late phases, so that later
survival extrapolation is less inﬂuenced by the early pattern. However, the later phase inevitably
contains fewer observations and therefore less information, with poorer mixing of related
parameters and typically wide credible intervals, as seen in the IT example. Instabilities may arise
in examples with fewer patients with long-term follow-up. Stronger priors may then be required for
convergence. Finally, in our experience, posterior distributions can be highly skewed so that DIC
estimates can be unreliable. Therefore, unless there is suﬃcient information extrapolations that rely
heavily on the later phase parameter estimates should not be made uncritically.
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Appendix 1
MCMC algorithm
Implementation of the poly-Weibull model in the freely available WinBUGS software can facilitate its
use by researchers in the area. However, model speciﬁcation using the BUGS language is not
straightforward as the likelihood is non-standard. Two basic options are available: (1) the
speciﬁcation of the non-standard likelihood by the use of ‘auxiliary data’ or (2) the implementation
of a new distribution in BUGS. The former method introduces an auxiliary observation to ‘replace’
each actual observation (complete or censored) in the data set. These are all assumed to be equal to 1,
say, and to have arisen from a Bernoulli distribution with parameter pi. The corresponding likelihood
is then i pi, which provides a mechanism for specifying arbitrary likelihood contributions from each
observation, by deﬁning pi accordingly. However, such an approach can be cumbersome to
implement. The second approach of incorporating a new distribution into the BUGS language has
several advantages: ﬁrst, the details of the often complex density are ‘packaged’ within a simple
modelling component, making for easier implementation (in particular by other users) and giving a
more concise model description, which is less prone to coding errors and easier to read and modify;
second, function evaluations implemented in ‘native code’ (Component Pascal) are generally faster;
and, ﬁnally, the Component Pascal language oﬀers much more ﬂexibility than the BUGS language.
We implement our new distribution by making use of the WinBUGS Development Interface.15
With respect to dealing with censoring, which is very common in survival applications, there are two
options: to integrate censored observations out of the model or to sample them as part of the
MCMC simulation. Although the latter approach is somewhat less eﬃcient, we choose this for
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several reasons. First, it ﬁts better with the mechanisms already existing within WinBUGS for
handling censored data. Second, it helps to maintain the separation of modelling assumptions
from data, since the former method would require censoring data to be passed to the poly-
Weibull distribution as input. Perhaps most importantly, however, the sampling approach can be
used in arbitrary settings/contexts (e.g. prior, likelihood and predictive distribution), without danger
of misuse, whereas the integration approach is naturally geared towards a likelihood assumption
and could not accommodate, for example, a censored observation with observed descendants in the
graph – one can never anticipate all possible uses of a new modelling component. The BUGS syntax
for our new distribution is given by T[i]  nd.dpolyweib(m, nu[], lambda[]), where T[i] is the
survival time for individual i; m the number of components in the poly-Weibull; and nu[] and
lambda[] vectors containing the m elements of  and l, respectively. In addition, the usual I(.,.)
construct can be used for censored observations, as shown in Appendix 2.
As the likelihood is speciﬁed in (3.1), WinBUGS only requires random samples from the censored
observations. This can be done by solving P(T t* | T> c) ¼ u, where t* denotes the random variate,
c the point of right censoring and u  U(0, 1) a sample from the uniform distribution. This translates
into solving SðcÞSðtÞSðcÞ ¼ u or eﬀectively
Pm
j¼1 ljt
j þ logðSðcÞ  SðcÞuÞ ¼ 0. It can be shown that a
unique solution exists but cannot be obtained analytically unless m¼ 1. We found that a simple
Newton–Raphson algorithm was adequate with robust performance for a very wide variety of input
combinations. The case of left censoring is treated analogously by solving
Pm
j¼1 ljt
j þ logðSðbÞ
ð1 SðbÞÞuÞ ¼ 0, where b denotes the left censoring point.
Appendix 2
WinBUGS program
Here, we present an example of the programs we used in the IT example. This particular model
allows diﬀerent intercept (beta0) and slope (beta1) for the rate parameters of each of the two
hazard components. The ordering constraint for the shape parameters is applied by making use
of auxiliary data. We suppose that we have observed a Bernoulli random variable b, equal to 1, and
that the associated ‘success probability’ is g¼ I(2 1). The auxiliary observation b constrains the
joint prior p(1, 2) by contributing a likelihood term that only supports 1<2.
for (i in 1:N) {t[i]  nd.dpolyweib(2, nu[], lambda[,i])I(t.cen[i],)}
for (j in 1:2) {
for (i in 1:N) {log(lambda[j,i]) <- beta0[j] + beta1[j]*IT[i]}
beta0[j]  dnorm(0, 0.0001)
beta1[j]  dnorm(0, 0.0001)
}
nu[1]  dunif(0, 1)
log(nu[2]) <- log.nu2
log.nu2  dnorm(0, 0.7432)
b <- 1
b  dbern(gamma)
gamma <- step(nu[2] - nu[1])
Data:
list(N¼4335, t¼c(7.292, NA, 0.8295, ...), t.cen¼c(0, 10.0246, 0, ...))
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If we wish to allow covariate eﬀects for the shape parameters also, then g is redeﬁned as described
towards the end of Section 3.2. For example,
for (i in 1:N) {t[i]  nd.dpolyweib(2, nu[,i], lambda[,i])I(t.cen[i],)}
for (j in 1:2) {
for (i in 1:N) {log(lambda[j,i]) <- beta0[j] + beta1[j]*IT[i]}
for (i in 1:N) {log(nu[j,i]) <- alpha0[j] + alpha1[j]*IT[i]}
beta0[j]  dnorm(0, 0.0001)
beta1[j]  dnorm(0, 0.0001)
alpha0[j]  dnorm(0, 0.0001)
alpha1[j]  dnorm(0, 0.0001)
}
C11 <- step(min(w[2,1],w[2,2]) - min(w[1,1],w[1,2]))
C21 <- step(max(w[2,1],w[2,2]) - max(w[1,1],w[1,2]))
for (j in 1:2) {
w[j,1] <- alpha0[j] + alpha1[j]*min(IT[])
w[j,2] <- alpha0[j] + alpha1[j]*max(IT[])
}
b <- 1
b  dbern(gamma)
gamma <- C11 * C21
For cases in which there are two or more covariates, a more general minmax(.) function, which
returns the minimum and maximum values from its vector argument, can be downloaded from the
WinBUGS Development web site (http://www.winbugs-development.org.uk/) as a part of the
‘WBDev shared components’
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